Dachaigh › Aillse anns an t-sruthan bile (Cholangiocarcinoma) › California
Sgrùdaidhean clionaigeach Aillse anns an t-sruthan bile (Cholangiocarcinoma) ann an California
Tha 20 sgrùdaidhean airson Aillse anns an t-sruthan bile (Cholangiocarcinoma) a’ lorg phàirtichean aig làraichean ann an California.
Bailtean ann an California
- Los Angeles7 sgrùdaidhean
- Mountain View5 sgrùdaidhean
- Baldwin Park5 sgrùdaidhean
- Orange4 sgrùdaidhean
- San Francisco3 sgrùdaidhean
- Santa Monica3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06840886A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- City of Hope (Site 107), Duarte
- University of California at Irvine (Site 101), Orange
- UCLA Medical Center (Site 117), Santa Monica
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START Los Angeles, Los Angeles
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07488676Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Stanford University, Palo Alto
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05732831Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07619313Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- UCI Irvine Health, Orange
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07486713Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
- City of Hope Medical Center, Duarte
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT05285358A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
A’ fastadhÌre 2
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
- USC Norris Comprehensive Cancer Center, Los Angeles
- LACN Aneheim Flagship Office, Los Angeles
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT05874414A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- USC Norris Comprehensive Cancer Center, Los Angeles
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07337525A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- City of Hope Nat Medical Ctr, Duarte
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07224750An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
- City of Hope Medical Center, Duarte
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT06342414A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT07169734Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
- University of California, Davis Comprehensive Cancer Center, Sacramento
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT06101277A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Cedars-Sinai Medical Center, Los Angeles
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT07458347A Study of MGC028 in Participants With Advanced Solid Tumors
- UCSF - Helen Diller Family Cancer Center, San Francisco
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT06723236REGULUS: MRI-guided Adaptive SABR for Liver Cancers
- Stanford University, Palo Alto
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gearr 2026 · NCT07223307SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- agus 3 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.